Today: 9 June 2026
Caesars stock jolts on Fertitta takeover chatter — what CZR investors watch next
27 February 2026
1 min read

Caesars stock jolts on Fertitta takeover chatter — what CZR investors watch next

New York, Feb 27, 2026, 08:41 EST — Premarket

  • Caesars shares jumped about 19% on Thursday, following a report that the company might be weighing takeover interest.
  • The report flagged interest from a group linked to Tilman Fertitta, while also noting a possible management buyout.
  • Traders look for more disclosures and signals on financing, with rate swings still in the background.

Shares of Caesars Entertainment (CZR.O) shot up about 19% Friday, after reports that the casino operator is weighing takeover bids—including an offer linked to billionaire Tilman Fertitta, according to .

Eyes are on Caesars, loaded with U.S. gaming leverage, as the take-private bid hangs on debt markets staying open and not too costly. Caution is setting in among investors. “Headline rallies” have fizzled before, sometimes vanishing the moment a fresh filing lands—or doesn’t.

Caesars is mulling bids from multiple suitors and has even explored a management buyout scenario that would involve company executives teaming up with financial sponsors to take it private, the Financial Times reports. Talks remain active but could still collapse, according to the same report. With debt topping $20 billion, Caesars presents a tough challenge for any potential buyer.

The stock closed out Thursday at $24.74, up 19.11%. It swung between $20.85 and $25.08 during the session as volume spiked, with about 16.9 million shares traded.

MGM Resorts, Las Vegas Sands, and DraftKings each finished higher, but none matched the surge in Caesars, MarketWatch said.

Caesars Digital just posted its best quarter yet, CEO Tom Reeg said earlier this month. Looking ahead, Reeg told investors that by 2026, the company’s free cash flow is slated for paying down debt and, when the opportunity presents itself, buying back shares—a choice of words that tends to gain significance whenever acquisition chatter picks up around a company carrying this much leverage.

Wall Street showed caution just a day ago. On Wednesday, Morgan Stanley trimmed its Caesars price target to $25 from $27, maintaining an “equal weight” rating, MarketBeat reported. The adjustment underscored how quickly attention shifted away from fundamentals and zeroed in on deal math. MarketBeat

Macro factors are in the mix too. The Labor Department said U.S. producer prices jumped 0.5% in January, with the core PPI—excluding food, energy and trade services—up 0.3%. Numbers like that could shake up rate expectations, and that feeds directly into the cost of funding a leveraged buyout.

Buyout rumors come cheap; the financing, not so much. If would-be acquirers get cold feet over Caesars’ massive debt load, lease commitments, or the daunting amount of cash needed, the stock could quickly reverse course — especially if the company stays silent.

Traders are now waiting for either a statement from Caesars or more concrete reporting. Looking ahead, new U.S. economic data looms next week: the ISM manufacturing PMI lands March 2, followed by February jobs figures on March 6. Both could move yields and appetite for risk ahead of any final deal funding.

Stock Market Today

  • Cotton Futures Close Mixed with Slight Gains and Losses on Monday
    June 8, 2026, 8:14 PM EDT. Cotton futures ended Monday with mixed results, ranging from 36 points lower to 13 points higher across contracts. The US dollar index fell to 99.95, while crude oil rose by 74 cents. The USDA Crop Progress report showed 77% of the US cotton crop planted, matching average pace, with 53% rated in good to excellent condition, up from last year. ICE certified cotton stocks increased by 11,219 bales to 261,648. Key contract closes included July 26 Cotton down 36 points at 73.39 cents per pound, December 26 Cotton up 13 points at 77.61 cents, and March 27 Cotton up 7 points at 78.87 cents. The Cotlook A Index and Adjusted World Price declined, reflecting ongoing market volatility.

Latest articles

Nasdaq rebounds after hours as chip stocks swing back

Nasdaq rebounds after hours as chip stocks swing back

9 June 2026
Nasdaq jumped 0.86% as chip stocks rebounded, with Intel soaring 11.2% on news Google ordered over 3 million AI chips for 2028, while Apple slid 1.9% after unveiling new AI features. Investors await Wednesday’s May CPI inflation report, which could spark volatility in tech and growth stocks.
Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

9 June 2026
Broadcom shares jumped 2.8% to $396.60 as chip stocks rebounded after last week’s $1 trillion sector wipeout, but investors remain cautious after Broadcom’s Q2 revenue missed expectations and the company declined to raise its 2027 AI revenue forecast, fueling concerns that rapid AI growth may not meet Wall Street’s high demands.
BitMine Stock Gains as Ether Holdings Approach 5% Target

BitMine Stock Gains as Ether Holdings Approach 5% Target

9 June 2026
BitMine Immersion Technologies shares jumped 6% after revealing ether holdings climbed to 5.54 million tokens, now 4.59% of Ethereum’s supply, with $9.6 billion in crypto, cash and stakes. The company priced a $273.8 million preferred stock offering, with proceeds possibly funding more ETH purchases and staking. BitMine projects $230 million in annualized staking revenues but warns of risks if ETH or financing falters.
Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal
Previous Story

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal

CBA’s $1 Billion Mortgage Fraud Alarm: Big Banks Face New AI-Document Threat
Next Story

CBA’s $1 Billion Mortgage Fraud Alarm: Big Banks Face New AI-Document Threat

Go toTop